Evidence map›Paper›PMID 34516978›Full record

ArticleEnvironmental research2022

Arsenic exposure and human blood DNA methylation and hydroxymethylation profiles in two diverse populations from Bangladesh and Spain.

Arce Domingo-Relloso, Anne Bozack, Samara Kiihl, Zulema Rodriguez-Hernandez, Pilar Rentero-Garrido, J Antonio Casasnovas, Montserrat Leon-Latre, Tamara Garcia-Barrera, J Luis Gomez-Ariza, Belen Moreno and 10 more

Open access · greenAbstract read
In one paragraph

Article in Environmental research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Epigenomic reprogramming in iAs-mediated carcinogenesis.Advances in pharmacology (San Diego, Calif.) · 2023
    Article
  7. Review
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 9 institutions in 3 countries.

Arce Domingo-RellosoIntegrative Epidemiology Group, Department of Chronic Diseases Epidemiology, National Center for Epidemiology, Instituto de Salud Carlos III, Madrid, Spain; Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, USA; Department of Statistics and Operations Research, University of Valencia, Spain.
Anne BozackDepartment of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, USA; Department of Environmental Health Sciences, School of Public Health, University of California, Berkeley, USA.
Samara KiihlDepartment of Statistics, State University of Campinas, Brazil.
Zulema Rodriguez-HernandezIntegrative Epidemiology Group, Department of Chronic Diseases Epidemiology, National Center for Epidemiology, Instituto de Salud Carlos III, Madrid, Spain.
Pilar Rentero-GarridoPrecision Medicine Unit, Biomedical Research Institute Hospital Clinic de Valencia INCLIVA, Valencia, Spain.
J Antonio CasasnovasCIBERCV, And Aragon Health Research Institute Foundation (IIS Aragon), University of Zaragoza, Zaragoza, Spain; Aragon Health Research Institute Foundation (IIS Aragon), University of Zaragoza, Zaragoza, Spain.
Montserrat Leon-LatreCIBERCV, And Aragon Health Research Institute Foundation (IIS Aragon), University of Zaragoza, Zaragoza, Spain; Aragon Health Research Institute Foundation (IIS Aragon), University of Zaragoza, Zaragoza, Spain.
Tamara Garcia-BarreraResearch Center on Natural Resources, Health and the Environment, Department of Chemistry, University of Huelva, Huelva, Spain.
J Luis Gomez-ArizaResearch Center on Natural Resources, Health and the Environment, Department of Chemistry, University of Huelva, Huelva, Spain.
Belen MorenoAragon Health Research Institute Foundation (IIS Aragon), University of Zaragoza, Zaragoza, Spain; Department of Microbiology, Pediatrics, Radiology and Public Health, University of Zaragoza, Zaragoza, Spain.
Ana CenarroCIBERCV, And Aragon Health Research Institute Foundation (IIS Aragon), University of Zaragoza, Zaragoza, Spain; Aragon Health Research Institute Foundation (IIS Aragon), University of Zaragoza, Zaragoza, Spain.
Griselda de MarcoGenomics Area, Foundation for the Promotion of Health and Biomedical Research of the Valencian Region (FISABIO), Valencia, Spain.
Faruque ParvezColumbia University Arsenic Project in Bangladesh, Dhaka, Bangladesh.
Abu B SiddiqueColumbia University Arsenic Project in Bangladesh, Dhaka, Bangladesh.
Hasan ShahriarColumbia University Arsenic Project in Bangladesh, Dhaka, Bangladesh.
Mohammad N UddinColumbia University Arsenic Project in Bangladesh, Dhaka, Bangladesh.
Tariqul IslamColumbia University Arsenic Project in Bangladesh, Dhaka, Bangladesh.
Ana Navas-AcienDepartment of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, USA.
Mary GambleDepartment of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, USA.
Maria Tellez-PlazaIntegrative Epidemiology Group, Department of Chronic Diseases Epidemiology, National Center for Epidemiology, Instituto de Salud Carlos III, Madrid, Spain. Electronic address: m.tellez@isciii.es.
Universidad de Zaragoza · ESColumbia University · USInstituto de Salud Carlos III · ESUniversidad de Huelva · ESCenter for Environmental Health · USFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana · ESINCLIVA Health Research Institute · ESUniversidade Estadual de Campinas (UNICAMP) · BRUniversitat de València · ES

Funding

Tumor Biology and Microenvironment ProgramP30CA013696 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Anil K Rustgi · 1985 to 2026
$115.3M
Training CoreP42ES010349 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI NAVAS-ACIEN, ANA · 2000 to 2020
$53.6M
True Metal fac coreP30ES009089 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Steven N. Chillrud · 1998 to 2026
$44.7M
Supplemental Training in Making Data FAIR and AI/ML ReadyT32ES007322 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Pam R Factor-Litvak, Allison Kupsco · 2000 to 2026
$12.1M
Metabolomic and nutrigenetic effects of folic acid supplementation and unmetabolized folic acidR01DK123285 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GAMBLE, MARY · 2020 to 2023
$2.6M
Folic Acid and Creatine as Therapeutic Approaches for Lowering Blood ArenicR01CA133595 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GAMBLE, MARY · 2009 to 2013
$2.3M
Effects of Arsenic Exposure on 5-methylcytosine and 5-hydroxymethylcytosine, and Effect Modification by Nutritional StatusF31ES029019 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BOZACK, ANNE KRISTINA · 2018 to 2019
$48k
NCI NIH HHS P30 CA013696NCI NIH HHS R01 CA133595NIDDK NIH HHS R01 DK123285NIEHS NIH HHS F31 ES029019NIEHS NIH HHS P30 ES009089NIEHS NIH HHS P42 ES010349NIEHS NIH HHS T32 ES007322
6 · The paper itself

Abstract

backgroundAssociations of arsenic (As) with the sum of 5-mC and 5-hmC levels have been reported; however, As exposure-related differences of the separated 5-mC and 5-hmC markers have rarely been studied.

methodsIn this study, we evaluated the association of arsenic exposure biomarkers and 5-mC and 5-hmC in 30 healthy men (43-55 years) from the Aragon Workers Health Study (AWHS) (Spain) and 31 healthy men (31-50 years) from the Folic Acid and Creatinine Trial (FACT) (Bangladesh). We conducted 5-mC and 5-hmC profiling using Infinium MethylationEPIC arrays, on paired standard and modified (ox-BS in AWHS and TAB in FACT) bisulfite converted blood DNA samples.

resultsThe median for the sum of urine inorganic and methylated As species (ΣAs) (μg/L) was 12.5 for AWHS and 89.6 for FACT. The median of blood As (μg/L) was 8.8 for AWHS and 10.2 for FACT. At a statistical significance p-value cut-off of 0.01, the differentially methylated (DMP) and hydroxymethylated (DHP) positions were mostly located in different genomic sites. Several DMPs and DHPs were consistently found in AWHS and FACT both for urine ΣAs and blood models, being of special interest those attributed to the DIP2C gene. Three DMPs (annotated to CLEC12A) for AWHS and one DHP (annotated to NPLOC4) for FACT remained statistically significant after false discovery rate (FDR) correction. Pathways related to chronic diseases including cardiovascular, cancer and neurological were enriched.

conclusionsWhile we identified common 5-hmC and 5-mC signatures in two populations exposed to varying levels of inorganic As, differences in As-related epigenetic sites across the study populations may additionally reflect low and high As-specific associations. This work contributes a deeper understanding of potential epigenetic dysregulations of As. However, further research is needed to confirm biological consequences associated with DIP2C epigenetic regulation and to investigate the role of 5-hmC and 5-mC separately in As-induced health disorders at different exposure levels.

Indexed as

ArsenicBangladeshDNA MethylationEpigenesis, GeneticHumansLectins, C-TypeMaleNuclear ProteinsReceptors, MitogenSpainArsenicCLEC12A protein, humanLectins, C-TypeNPLOC4 protein, humanNuclear ProteinsReceptors, MitogenArsenicDNA hydroxymethylationDNA methylationEpigenetics

Identifiers

PMID34516978
PMCPMC8734953
OpenAlexW3200353971

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.